chenodeoxycholic acid has been researched along with Pulmonary Fibrosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adorini, L; Comeglio, P; Maggi, M; Morelli, A; Vignozzi, L | 1 |
| Adorini, L; Cellai, I; Comeglio, P; Corno, C; Filippi, S; Maggi, M; Morelli, A; Pini, A; Sarchielli, E; Vannelli, GB; Vignozzi, L | 1 |
| Adorini, L; Cellai, I; Comeglio, P; Corno, C; Filippi, S; Maggi, M; Morelli, A; Sarchielli, E; Vannelli, GB; Vignozzi, L | 1 |
| Adorini, L; Cellai, I; Comeglio, P; Corcetto, F; Corno, C; Filippi, S; Maggi, M; Maneschi, E; Morelli, A; Pini, A; Sarchielli, E; Vannelli, GB; Vignozzi, L | 1 |
1 review(s) available for chenodeoxycholic acid and Pulmonary Fibrosis
| Article | Year |
|---|---|
Beneficial effects of bile acid receptor agonists in pulmonary disease models.
Topics: Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Drug Design; Humans; Inflammation; Lung Diseases; Molecular Targeted Therapy; Pulmonary Fibrosis; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled | 2017 |
3 other study(ies) available for chenodeoxycholic acid and Pulmonary Fibrosis
| Article | Year |
|---|---|
Therapeutic effects of obeticholic acid (OCA) treatment in a bleomycin-induced pulmonary fibrosis rat model.
Topics: Animals; Antibiotics, Antineoplastic; Biomarkers; Bleomycin; Chenodeoxycholic Acid; Disease Models, Animal; Epithelial-Mesenchymal Transition; Male; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley | 2019 |
Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Chenodeoxycholic Acid; Disease Models, Animal; Hypertension, Pulmonary; Male; Monocrotaline; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear | 2019 |
Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.
Topics: Airway Remodeling; Animals; Bleomycin; Chenodeoxycholic Acid; Collagen; Disease Models, Animal; Fibrosis; Gene Expression Profiling; Immunohistochemistry; Inflammation; Lung; Male; Pulmonary Alveoli; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Ventricular Remodeling | 2017 |